RNF40 antibody
Principal name
RNF40 antibody
Alternative names for RNF40 antibody
RING finger protein 40, BRE1B, BRE1-B, RBP95, KIAA0661, E3 ubiquitin-protein ligase BRE1B, 95 kDa retinoblastoma-associated protein
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), Frozen Sections (C)
Background of RNF40 antibody
RNF40 contains a RING finger, a motif known to be involved in protein-protein and protein-DNA interactions. This protein was reported to interact with the tumor suppressor protein RB1. Studies of the rat counterpart suggested that this protein may function as an E3 ubiquitin-protein ligase, and facilitate the ubiquitination and degradation of syntaxin 1, which is an essential component of the neurotransmitter release machinery.The protein encoded by this gene contains a RING finger, a motif known to be involved in protein-protein and protein-DNA interactions. This protein was reported to interact with the tumor suppressor protein RB1. Studies of the rat counterpart suggested that this protein may function as an E3 ubiquitin-protein ligase, and facilitate the ubiquitination and degradation of syntaxin 1, which is an essential component of the neurotransmitter release machinery.
General readings
Zhu,B., (2005) Mol. Cell 20 (4), 601-611





Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP54908PU-N | RNF40 antibody |
||||||
![]() |
Rabbit | Purified | Hu | C, E, WB |
0.1 mg /
€450.00
|
||
| OriGene Technologies GmbH | |||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR211421L2V | Lenti ORF particles, Rnf40 (GFP-tagged) - Mouse ring finger protein 40 (Rnf40), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,890.00
|
|
| OriGene Technologies, Inc. | ||
| MR211421L1V | Lenti ORF particles, Rnf40 (Myc-DDK-tagged) - Mouse ring finger protein 40 (Rnf40), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,700.00
|
|
| OriGene Technologies, Inc. | ||



